Featured News
![](/sites/default/files/styles/4_3_medium/public/2022/06/14/image%2059.png?itok=Ho2CIWYA)
AIM Blog
A New Era of Alzheimer’s Treatment and Care
When nearly 14,000 researchers recently joined for the Alzheimer’s Association International Conference (AAIC), the latest and greatest in Alzheimer’s and dementia research was on display. Throughout ...
All News
![Woman Advocate](/sites/default/files/styles/4_3_small/public/2022/07/29/AA%20Woman%20Inside%20Hotel%2C%20Vertical.jpg?itok=TgKhT2-_)
Press Release
Critical Alzheimer’s and Dementia Priorities Signed Into Law
Washington, D.C., December 29, 2022 – The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) commend the passage of the...
Press Release
Congress Prioritizes Addressing Alzheimer’s and Dementia
Key provisions of the ENACT Act, language to strengthen FDA accelerated approval pathway, a $226 million increase for Alzheimer’s and...
![Scientist at Microscope](/sites/default/files/styles/4_3_small/public/2022/12/20/Scientist-Using-Microscope-in-Laboratory-909176662_7360x4912%20%283%29_0.jpeg?itok=L4AC7J1K)
Press Release
Alzheimer’s Association Calls on CMS to Reverse Its Decision to Severely Limit Access to FDA-Approved Alzheimer’s Disease Treatments
Association Files Formal Request for Reconsideration of National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of...
![Joanne, Rob and Laura at DSC Summit](/sites/default/files/styles/4_3_small/public/2022/12/06/IMG_6933%20%281%29.jpg?itok=D14PlaDs)
AIM Blog
Alzheimer’s Association Hosts Inaugural State Dementia Services Coordinator Summit
At the end of October, the Alzheimer’s Association hosted the inaugural State Dementia Services Coordinator (DSC) Summit in Washington, D.C...
![Couple with Doctor](/sites/default/files/styles/4_3_small/public/2022/07/22/White%20Couple%20with%20Doc.jpg?itok=MiQcPehD)
Press Release
Alzheimer’s Association Statement On Gantenerumab Phase 3 Topline Data Release
Chicago, November 14, 2022 — The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech...
![Joanne at Forum](/sites/default/files/styles/4_3_small/public/2022/10/25/2022_AIM_DC_Wednesday-45.jpg?itok=ojjhai5a)
Press Release
Alzheimer’s Impact Movement Names Dr. Joanne Pike its Next President and Chief Executive Officer
Washington, D.C., October 26, 2022 – Joanne Pike, DrPH, current president of the Alzheimer’s Association, will become the president and...